Skip to main content
OpenTrials
Completed

NCT Number: NCT03026322

Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial

Complications are common during endotracheal intubation of critically ill adults. Manual ventilation between induction and intubation ("bag-valve-mask" ventilation) has been proposed as a means of preventing hypoxemia, the most common complication of intubation outside the operating room. Safety and efficacy data, however, are lacking. PreVent is a randomized trial comparing manual ventilation between induction and laryngoscopy to no manual ventilation between induction an laryngoscopy during endotracheal intubation of critically ill adults. The primary efficacy endpoint will be the lowest arterial oxygen saturation. The primary safety endpoints will be the lowest oxygen saturation, highest fraction of inspired oxygen, and highest positive end-expiratory pressure in the 24 hours after the procedure.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The University of Alabama at Birmingham, Birmingham, Alabama, United States

Loading trial locations.

About this study

PreVent is a prospective, parallel-group, pragmatic, randomized trial comparing manual ventilation between induction and laryngoscopy to no manual ventilation between induction an laryngoscopy during endotracheal intubation of critically ill adults. The primary aim of the PreVent trial is to compare the effect of manual ventilation between induction and intubation versus no manual ventilation on the lowest arterial oxygen saturation experienced by critically ill adults undergoing endotracheal intubation. The PreVent trial is anticipated to begin enrollment in January 2017 and will enroll adults undergoing endotracheal intubation with sedation and/or neuromuscular blockade in participating units. Patients will be randomized 1:1 to manual ventilation versus no manual ventilation. In the manual ventilation group, manual ventilation using a bag-valve-mask will be provided from the time of induction until the time of endotracheal intubation, except during laryngoscopy. In the no manual ventilation group, no manual ventilation will be provided between induction and endotracheal intubation, except for the treatment of hypoxemia. The primary efficacy endpoint will be the lowest arterial oxygen saturation during the procedure. The primary safety endpoints will be the lowest oxygen saturation, highest fraction of inspired oxygen, and highest positive end expiratory pressure in the 24 hours after intubation. Conduct of the trial will be overseen by a Data Safety Monitoring Board. An interim analysis will be performed after the enrollment of 175 patients. The analysis of the trial will be conducted in accordance with a pre-specified statistical analysis plan made publicly available prior to the conclusion of enrollment. The initial planned enrollment of 350 patients was increased by the Data and Safety Monitoring Board at the interim analysis to a final planned enrollment of 400 patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient is located in a participating unit
  • Planned procedure is endotracheal intubation
  • Planned operator is a provider expected to routinely perform endotracheal intubation in the participating unit
  • Administration of sedation and/or neuromuscular blockade is planned
  • Age ≥ 18 years old

Exclusion criteria

  • Urgency of intubation precludes safe performance of study procedures
  • Operator feels a specific approach to ventilation between induction and intubation is required
  • Pregnant women
  • Prisoners

Treatment and study plan

manual ventilation

Other

Beginning after the administration of sedation/neuromuscular blockade, manual ventilation will be provided by bag-valve-mask until the initiation of laryngoscopy. In patients requiring more than one attempt at laryngoscopy, bag-valve-mask ventilation will resume between laryngoscopy attempts.

Other names: Bag-valve-mask ventilation

No Manual Ventilation

Other

Between the administration of sedation/neuromuscular blockade and intubation, ventilation will not be provided unless the patient experiences an arterial oxygen saturation less than 90%. For patients who experience an oxygen saturation less than 90% after induction, bag-valve-mask ventilation may be provided.

Other names: Apnea

Primary outcomes

  1. Lowest arterial oxygen saturation

    Time frame: Induction to 2 minutes after completion of the airway management procedure

    The lowest arterial oxygen saturation measured by continuous pulse oximetry (SpO2) between induction and 2 minutes after completion of the airway management procedure.

Secondary outcomes

  1. Incidence of lowest oxygen saturation less than 90%

    Time frame: Induction to 2 minutes after completion of the airway management procedure

    Incidence of lowest oxygen saturation less than 90% in the time from induction to 2 minutes after completion of the airway management procedure.

  2. Incidence of lowest oxygen saturation less than 80%

    Time frame: Induction to 2 minutes after completion of the airway management procedure

    Incidence of lowest oxygen saturation less than 80% in the time from induction to 2 minutes after completion of the airway management procedure.

  3. Change in saturation from induction to lowest oxygen saturation

    Time frame: Induction to 2 minutes after completion of the airway management procedure

    Change in saturation from induction to lowest oxygen saturation within 2 minutes after completion of the airway management procedure.

  4. Incidence of desaturation

    Time frame: Induction to 2 minutes after completion of the airway management procedure

    Incidence of desaturation as defined by a decrease in oxygen saturation of greater than 3% from induction to lowest oxygen saturation within 2 minutes after completion of the airway management procedure.

  5. Lowest oxygen saturation in the 24 hours after intubation.

    Time frame: 24 hours after intubation

  6. Highest fraction of inspired oxygen in the 24 hours after intubation.

    Time frame: 24 hours after intubation

  7. Highest positive end expiratory pressure in the 24 hours after intubation.

    Time frame: 24 hours after intubation

  8. Lowest oxygen saturation, highest fraction of inspired oxygen, and highest positive end expiratory pressure from 0-1, 1-6, and 6- 24 hours after intubation.

    Time frame: 24 hours after intubation

    Lowest oxygen saturation, highest fraction of inspired oxygen, and highest positive end expiratory pressure from 0-1, 1-6, and 6- 24 hours after intubation.

  9. Operator-reported pulmonary aspiration

    Time frame: Induction to 2 minutes after completion of the airway management procedure

    Visualization of oropharyngeal or gastric contents in the pharynx, larynx, or trachea between induction and completion of airway management.

  10. New infiltrate on chest imaging in the 48 hours after intubation

    Time frame: 48 hours after intubation

    Determination of new infiltrate will be made by two blinded experts (pulmonary/critical care attendings or fellows) with adjudication by a third expert in the case of discordant results

  11. Operator-reported pulmonary aspiration, new chest x-ray infiltrate, OR lowest oxygen saturation < 80% (composite outcome)

    Time frame: 48 hours after intubation

  12. New pneumothorax or pneumomediastinum on chest imaging in the 24 hours after intubation

    Time frame: 24 hours after intubation

  13. Incidence of esophageal intubation

    Time frame: Induction to 2 minutes after completion of the airway management procedure

  14. Lowest systolic blood pressure (peri-procedural)

    Time frame: Induction to 2 minutes after completion of the airway management procedure

    Lowest systolic blood pressure between induction and two minutes after completion of the airway management procedure

  15. New systolic blood pressure < 65 mmHg or new need for vasopressor

    Time frame: Induction to 2 minutes after completion of the airway management procedure

    New systolic blood pressure < 65 mmHg or new need for vasopressor between medication administration and 2 minutes following successful placement of an endotracheal tube

  16. Cardiac arrest within one hour of intubation

    Time frame: One hour after intubation.

  17. Death within one hour of intubation

    Time frame: One hour after intubation

  18. Cormack-Lehane grade of glottic view

    Time frame: Induction to 2 minutes after completion of the airway management procedure

  19. Operator-assessed difficulty of intubation

    Time frame: Induction to 2 minutes after completion of the airway management procedure

  20. Incidence of successful intubation on the first laryngoscopy attempt

    Time frame: Induction to 2 minutes after completion of the airway management procedure

  21. Number of laryngoscopy attempts

    Time frame: Induction to 2 minutes after completion of the airway management procedure

  22. Time from induction to successful intubation

    Time frame: Induction to 2 minutes after completion of the airway management procedure

  23. Need for additional airway equipment or a second operator

    Time frame: Induction to 2 minutes after completion of the airway management procedure

  24. In-hospital mortality

    Time frame: 28 days

  25. Ventilator-free days

    Time frame: 28 days

    Ventilator-free days to day 28 will be defined as the number of days alive and with unassisted breathing to day 28 after enrollment, assuming a patient survives for at least two consecutive calendar days after initiating unassisted breathing and remains free of assisted breathing. If a patient returns to assisted breathing and subsequently achieves unassisted breathing prior to day 28, VFD will be counted from the end of the last period of assisted breathing to day 28. If the patient is receiving assisted ventilation at day 28 or dies prior to day 28, VFD will be 0. If a patient is discharged while receiving assisted ventilation, VFD will be 0. All data will be censored at the first of hospital discharge or 28 days.

  26. Intensive care unit-free days

    Time frame: 28 days

    ICU-free days to 28 days after enrollment will be defined as the number of days alive and not admitted to an intensive care unit service after the patient's final discharge from the intensive care unit in that hospitalization before 28 days. Patients who are never discharged from the intensive care unit will receive a value of 0. Patients who die before day 28 will receive a value of 0. For patients who return to an ICU and are subsequently discharged prior to day 28, ICU-free days will be counted from the date of final ICU discharge. All data will be censored at the first of hospital discharge or 28 days.

Sponsors and collaborators

Lead sponsor

Vanderbilt University Medical Center

Other

Registry information

Acronym: PreVent

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Jan 20, 2017
Registry last updated
Sep 13, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.